{"authors": [["Dick", "Chan", "C", "Metabolic Research Centre, School of Medicine, University of Western Australia, Crawley, Australia."], ["Hugh", "Barrett P", "BP", "Metabolic Research Centre, School of Medicine, University of Western Australia, Crawley, Australia."], ["Santica M", "Marcovina", "M", "Northwest Lipid Metabolism and Diabetes Research Laboratories, Perth, Australia."], ["Blai", "Coll Crespo", "CC", "Amgen, Inc, Thousand Oaks, USA."], ["Ransi", "Somaratne", "S", "Amgen, Inc, Thousand Oaks, USA."], ["Scott", "Rob", "R", "Amgen, Inc, Thousand Oaks, USA."], ["Scott M", "Wasserman", "W", "Amgen, Inc, Thousand Oaks, USA."], ["Watts", "Gerald F", "GF", "Metabolic Research Centre, School of Medicine, University of Western Australia, Crawley, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia."]], "text": "", "id": "29365989", "date": "2017-08-12", "title": "Apolipoprotein(a) isoform size may influence the production and catabolism of lipoprotein(a) particles in men.", "doi": "10.1016/j.atherosclerosis.2017.06.107", "journal": ["Atherosclerosis", "Atherosclerosis"]}